Abstract:Although genome-wide association studies (GWAS) have identified loci associated with Type 1 diabetes (T1D), the specific pathways and regulatory networks linking these loci to disease pathology remain largely unknown. We hypothesized that T1D genetic risk factors disrupt tissue-specific biological pathways and gene networks that ultimately lead to beta cell loss. We conducted a multitissue multiomics analysis that integrates human GWAS data for T1D with tissue-specific regulatory data on gene expression and gene network models across relevant tissues to highlight key pathways and key driver genes contributing to T1D pathogenesis. Key driver genes were validated using islet-specific gene expression and protein data from non-obese diabetic (NOD) mice compared to non-T1D mouse models. Drug repositioning predictions were generated using the L1000 and PharmOmics platforms. Our integrative genomics approach identified known immune pathways across multiple tissues, such as adaptive immune responses, cytokine-mediated inflammation, primary immunodeficiency, and interactions between lymphoid and non-lymphoid cells. Tissue-specific signals included genes related to type 2 diabetes in lymphocytes, viral response pathways in macrophages and monocytes, and Notch signaling in adipose and immune cells. In pancreatic islet analysis, we observed significant enrichment for T1D and type 2 diabetes gene sets alongside immune-related pathways, including antigen processing, systemic lupus erythematosus, and interferon signaling. Removing HLA genes from the analysis revealed additional immune pathways, such as RIG-I/MDA5 induction of interferons, along with melanogenesis, steroid hormone synthesis, and iron transport. Network modeling highlighted the autoimmune basis of disease with key drivers such as FYN, TAP1, WAS, and HLA-B/C/G, as well as further immunomodulatory genes such as LCK, LCP2, EMR1, and GC. These key drivers were further supported by gene and protein expression data from NOD mice. We additionally highlight various drug classes that target the T1D genetic networks and may be useful to delay T1D development. Our multitissue multiomics approach provides a detailed landscape of the tissue-specific genetic networks and regulators underlying T1D. This analysis confirms the roles of known immune pathways while uncovering additional regulatory elements and disease-associated networks, thus expanding our understanding of T1D pathogenesis. The identification of potential drug candidates through network analysis offers potential therapeutic strategies for targeting disease pathways and holds promise for delaying or preventing T1D progression.

Interpreting type 1 diabetes risk with genetics and single-cell epigenomics

Single cell chromatin accessibility reveals pancreatic islet cell type- and state-specific regulatory programs of diabetes risk

Single-cell chromatin accessibility identifies pancreatic islet cell type– and state-specific regulatory programs of diabetes risk

Single cell multiome profiling of pancreatic islets reveals physiological changes in cell type-specific regulation associated with diabetes risk

Genetic risk converges on regulatory networks mediating early type 2 diabetes

Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes

Elucidating the Epigenetic Landscape of Type 2 Diabetes: A Multi-Omics Analysis Revealing Novel CpG Sites and Their Association with Cardiometabolic Traits

Genetic variant effects on gene expression in human pancreatic islets and their implications for T2D

Pancreatic progenitor epigenome maps prioritize type 2 diabetes risk genes with roles in development

Risk Variants Disrupting Enhancers of T(H)1 and T-REG Cells in Type 1 Diabetes

A multi-ancestry genome-wide association study in type 1 diabetes

Systematic Functional Characterization of Candidate Causal Genes for Type 2 Diabetes Risk Variants

Comparative Multi-omic Mapping of Human Pancreatic Islet Endoplasmic Reticulum and Cytokine Stress Responses Provides Insights into Type 2 Diabetes Genetics

Rare Genetic Variants of Large Effect Influence Risk of Type 1 Diabetes

Genetic association and machine learning improves discovery and prediction of type 1 diabetes

Multitissue Multiomics Integration Reveals Tissue-Specific Pathways, Gene Networks, and Drug Candidates for Type 1 Diabetes

Multiomics single-cell analysis of human pancreatic islets reveals novel cellular states in health and type 1 diabetes

Discovering human diabetes-risk gene function with genetics and physiological assays

Identification of novel type 1 and type 2 diabetes genes by co-localization of human islet eQTL and GWAS variants with colocRedRibbon

Identification of Novel T1D Risk Loci and Their Association with Age and Islet Function at Diagnosis in Autoantibody-Positive T1D Individuals: Based on a Two-Stage Genome-Wide Association Study

CRISPR Screening Uncovers a Long-Range Enhancer for ONECUT1 in Pancreatic Differentiation and Links a Diabetes Risk Variant